NEWS
Drug trial failures gives CSL $8b of heart palpitations
MELBOURNE: On one view, the failure of CSL’s much anticipated heart-attack drug is a symbol… read more
Bupa becomes bigger VC player with $20m fund
SYDNEY: Health insurance company Bupa has launched a $20 million VC fund, Bupa Ventures, to… read more
Aged-care village set to start in tourism belt
WANAKA: Metlifecare is set to begin building Wānaka’s newest premium aged-care facility for up to… read more
